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   T－1220， a new broad antibacterial penicillin， was administered to patients with infections of
urinary tracts and male genital organs caused by Pseudomonas sP．， and the following results were ob－
tained．
1）Mini皿al inhibitory cgncentrations of T－1220， CBPC， SBPC， GM and DKB werc determined
on 23 strains of Pseudomonas sP． isolated clinically． Antibacterial activity of T－1220 was higher than
that of CBPC and SBPC．
   GM and DKB had superior activity to T－1220， but a few strains were resistant to GM and
DKB．
2） 11 patients with complicated urinary tract infections caused by Pseudomonas sp． were treated at
a daily dose of 4．一一6 g of T－1220 for 7．一v 17 days． The therapeutic results were excellent in 4 cases，
good in 6 cases and poor in 1 case， and the effective rate of these was 90．90／．．
3） The significant relationship between clinical result and MIC was not observed， but there was
a difference between the indwelling catheter group and the non－indwelling group and the excellent
effectiveness was observed in the non－indwelling catheter group more than in tihe indwelling group．
4） ln one case out of 11 cases， the elev4tion of GOT， GPT and alkaline phosphatase was observed．
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 2）成  績
 Pseudomonas sp．23株に対する各薬剤のMICは
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Fig． L Pseud・monas sp．．（23株）に対する薬剤感
受性の累積分布 横軸はMIC（μg／ml）．
Tablc 1・Pseudomonas sP・（株）に対する感受性分布
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Fig．2． Pseudomonas sp．（23株）に対する薬剤感
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有効 減 少 有効 鳳一溜8：琳3．13R．13 12．5U．25 一 有 臨床症?ﾁ失
6
一男














著効 ㎞ぬ一夢 200 一 『




? 有効 燃一濃駆上ﾛ交代。αηゴぬαあ加那 6．256．25 一 有 臨床症?ﾁ失














著効 燃一脚 12．5 25 一 一
11 男 64 53 慢性N胱前立腺床炎 前立腺摘除術後 2
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